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ABSTRACT: The formation and deposition of amyloids 
is associated with many diseases. β-Sheet secondary 
structure is a common feature of amyloids, but the pack-
ing of sheets against one another is distinctive relative to 
soluble proteins. Standard methods that rely on perturb-
ing a polypeptide’s sequence and evaluating impact on 
folding can be problematic for amyloid aggregates be-
cause a single sequence can adopt multiple confor-
mations and diverse packing arrangements. We describe 
initial steps toward a minimum-sized, soluble model 
system for the amyloid state that supports comparisons 
among sequence variants. Critical to this goal is devel-
opment of a new linking strategy to enable inter-sheet 
association mediated by side chain interactions, which is 
characteristic of the amyloid state. The linker design we 
identified should ultimately support exploration of rela-
tionships between sequence and amyloid state stability 
for specific strand-association modes. 
   Self-assembly of polypeptides to form amyloid depos-
its is thought to underlie many human diseases.1 Low-
resolution methods such as IR and x-ray fiber diffraction 
suggest that β-sheet secondary structure is a common 
motif in disease-relevant aggregated states, despite the 
variety of sequences and diversity of folding patterns 
among polypeptides known to form amyloids.2 Recent 
solid-state NMR studies have provided atomic-level 
structures for several amyloids, including those formed 
by the peptides Aβ(1-40) and Aβ(1-42), which are asso-
ciated with Alzheimer's Disease.3,4 These structural 
models display three common features. (1) Strand-
forming segments associate intermolecularly via in-
register parallel β-sheet H-bonding networks.5 The H-
bonds run along the fibril axis, and the peptide assem-
blies are therefore unbounded in this dimension. (2) At 
least one segment of each polypeptide forms a loop that 
causes reversal of backbone direction. (3) β-Sheet layers 
pack against one another via side chain-to-side chain 
contacts; the side chains are mostly nonpolar, which 
suggests a hydrophobic drive for amyloid assembly. The 
term "amyloid state" has been used to describe this spe-
cific combination of secondary and quaternary struc-
ture,6 which differs from the folding and assembly pat-
terns observed among soluble proteins.   
   Understanding of relationships between sequence and 
protein structural stability has emerged from the ability 
to disrupt natively folded states, typically via heating or 
chemical denaturation of proteins that are soluble and 
monomeric.7 This experimental approach allows one to 
evaluate how amino acid changes at individual sites af-
fect conformational stability, so long as the change does 
not substantially alter the folded structure.  The amyloid 
state, particularly as manifested by pathogenic exam-
ples,8 is not ideally suited for this structure-disruption 
approach because a single sequence, such as Aβ(1-40), 
can adopt multiple amyloid forms with different back-
bone conformations and side chain interaction pat-
terns.3,4,9 Therefore, it is not clear that a particular amy-
loid structure will be maintained when the identity of a 
residue is altered in a polypeptide that forms pathogenic 
amyloids.  (In contrast, functional amyloids,8 which are 
subject to evolutionary selection pressure, are amenable 
to the residue-variation approach, because the backbone 
conformation and assembly pattern persist in mutants.10)   
   Here we describe an important step toward a strategy 
for creating a minimum-sized, soluble model system for 
the amyloid state.11 This approach may ultimately sup-
port sequence-stability measurements relevant to the 
amyloid state.  Critical to our long-term goal is the abil-
ity to specify which portions of the design form β-strand 
segments, and which portions form inter-strand linkers.  
Our approach builds on previous development of small, 
parallel β-sheets in aqueous solution,12 which required a 
diamine reverse-turn unit to link peptide strands via their 
C-termini13 and a diacid to link peptide strands via their 
N-termini.14 To build toward a minimal amyloid motif, 
we envisioned face-to-face packing of an N-linked par-
allel β-sheet against a C-linked parallel β-sheet (Figure 
1A).  Critical to achieving this goal is identifying a way 
to link parallel β-sheets that promotes the side chain-
mediated association characteristic of the amyloid state, 
rather than the H-bond-mediated association characteris-
tic of a multi-strand β-sheet. 
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Figure 1. (A) Design of two-stranded parallel β-sheets 
based on linking strand segments via their C-termini (N-to-
N linker), or via their N-termini (C-to-C linker) (left), and 
the use of parallel β-sheets to generate a minimal model for 
the amyloid state, which requires a new type of interlayer 
linker (right). (B) Peptide 1. Intended strands indicated by 
colored arrows.  The strand indicated in green is deleted 
from 2.  Red stars indicate the positions in the β-arc that 
contain D residues in 1 and are altered in 3-5.  
   For guidance on the design of an inter-sheet linker, we 
turned to the multi-layered β-solenoid motif among sol-
uble proteins.15 Strand segments in neighboring β-
solenoid layers interact via parallel β-sheet H-bonds.  
Within each layer, the strand segments are linked via 
short loop-forming segments.  Strand segments in a giv-
en layer and in adjacent layers interact in a side chain-
to-side chain manner that is reminiscent of amyloid-state 
packing.  Kajava et al. have proposed the term "β-arch" 
to describe a β-solenoid strand-loop-strand motif in 
which the antiparallel strands interact exclusively via 
side chains;15a in contrast, strands in a "β-hairpin" inter-
act via H-bonds.16,17 The loop segment in a β-arch is 
designated a "β-arc".15a Bioinformatic analysis suggest-
ed that a β-arc must contain at least five residues to al-
low antiparallel orientation of attached strands with an 
interstrand separation sufficient for amyloid-like side 
chain-side chain contacts.  Among five-residue β-arcs, 
the most common local conformation at positions 1, 3 
and 4 displays standard β-sheet φ and ψ torsion angles 
(designated b). At positions 2 and 5, the φ and ψ torsion 
angles are consistent with a left-handed α-helix (desig-
nated l),15a a local conformation that is rare in proteins. 
The PDB has grown considerably since the original 
study,15 and we therefore updated the analysis of five-
residue β-arcs, confirming the prevalence of the blbbl 
conformation.18  
   Our mini-amyloid design hypothesis features D-Ala at 
β-arc residues 2 and 5, to favor l conformations at these 
sites (1, Figure 1B).  The most common L-residues18 
were placed at β-arc positions 1 (Arg) and 4 (His), while 
Ser was placed at 3 rather than the more common Cys, 
to avoid redox complications.  Statistical preferences 
guided our choice of the strand segments immediately 
adjacent to the β-arc, Ile-Arg-Met and Phe-Trp-Val. The 
remaining strand residues in 1 were chosen based on: (1) 
high β-sheet propensity, (2) net positive charge, to en-
sure solubility at acidic pH, and (3) maximal residue 
diversity, to promote 1H NMR resonance dispersion.   
 
Figure 2. Secondary α-proton chemical shifts of peptides 1 
(black bars) and 2 (gray bars). NMR spectra were obtained 
at 5º C, with 0.2 mM peptide, in 9:1 H2O:D2O, 2.5 mM 
NaOAc-d3, pH 3.8. Random coil values were calculated 
using CSDb2. 
   Peptide 1 appeared to be monomeric over the concen-
tration range 0.02-0.2 mM in 3 mM aqueous sodium 
acetate buffer, pH 3.8, based on NMR diffusion meas-
urements (DOSY) and analytical ultracentrifugation 
(AUC). 2D NMR measurements (COSY, TOCSY and 
NOESY) for 0.2 mM 1 in 9:1 H2O:D2O, 3 mM NaOAc-
d3, pH 3.8, 5o C, allowed assignment of almost all pro-
ton resonances.  Figure 2 summarizes chemical shift 
data from the α-protons of the residues in 1 that are in-
tended to adopt strand conformations; we plot the pa-
rameter ΔδαH = δαH(1) - δαH(random coil).19 Residues 
involved in β-sheet secondary structure tend to display 
positive ΔδαH values, while residues in α-helices tend to 
display negative ΔδαH values.20  The generally positive 
ΔδαH values for 1 are consistent with population of the 
mini-amyloid folding pattern.  Peptide 2, the analogue of 
1 that lacks the T1-V5 strand, does not display a con-
sistent positive trend among ΔδαH values, which sug-
gests that a minimum degree of hydrophobic side chain 
burial is necessary to drive mini-amyloid folding. 
   To gain further insight on the folding of 1 in aqueous 
solution, we examined NOEs between protons on resi-
dues that are not adjacent in sequence, which provide 
strong qualitative evidence for the presence of compact 
conformations. Parallel β-sheet secondary structure is 
associated with a characteristic NOE pattern involving 
an amide N-H that serves as an H-bond donor and CαH 
of the residue aligned on the neighboring strand.21 Two 
CαH--HN NOEs of this type are observed between the 
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strands connected by the N-to-N linker, and three are 
observed between the strands connected by the C-to-C 
linker (red arrows, Figure 3). Several longer-range 
NOEs suggest side chain-mediated packing of one paral-
lel β-sheet against the other (blue arrows).  These diag-
nostic NOEs are consistent with partial population of the 
mini-amyloid folding pattern.  1H resonances of 1 be-
come less dispersed as temperature is raised,18 suggest-
ing that the degree of mini-amyloid folding decreases at 
elevated temperature. 
 
Figure 3. Backbone-backbone NOEs (red) and NOEs in-
volving at least one side chain proton (blue) for peptide 1 
(0.2 mM in 9:1 H2O:D2O, 2.5 mM NaOAc-d3, pH 3.8, 5 
ºC). 
   Circular dichroism (CD) in the far-UV region arises 
largely from backbone amide groups and therefore pro-
vides insight on secondary structure.22 Peptide 1 (0.2 
mM in 2.5 mM aqueous NaOAc, pH 3.8) displays a 
moderate minimum at ~220 nm (Figure 4), suggesting a 
modest amount of β-sheet secondary structure, as ex-
pected if the mini-amyloid state is partially populated.  
In contrast, truncated peptide 2 does not show a mini-
mum in this region.   
   In order to test our β-arc design hypothesis, we used 
CD to compare 1 with full-length analogues varying 
only in the β-arc segment. Peptide 3, the diastereomer of 
1 with two D-AlaàL-Ala changes in the β-arc, lacks a 
minimum between 210 and 220 nm, suggesting little or 
no β-sheet. This observation is consistent with the bioin-
formatics-derived conclusion that amyloid-like folding 
requires left-handed α-helix torsion angles at positions 2 
and 5 of the β-arc.  In 4, β-arc positions 2 and 5 are L-
Asn, the residue we found to be most common in these 
positions of natural β-arcs.18 The CD data for 4 suggest 
that L-Asn in these positions is not significantly better 
than L-Ala in promoting amyloid-like folding.  The CD 
signature of 5, which has Gly residues at β-arc positions 
2 and 5, is very similar to that of 4.  2D NMR analysis 
of peptides 3-5 indicated lower dispersion of resonances 
relative to 1, which supports the conclusion that 3-5 do 
not adopt a specific folding pattern, in contrast to the 
mini-amyloid folding of 1.  The lower NMR dispersion 
precluded NOE assignment for 3-5.  
   To try to approach physiological ionic strength, we 
analyzed 0.1 mM 1 in pH 3.8 buffer containing 100 mM 
NaCl by NMR, CD and AUC; the data indicated in-
creased β-sheet content and self-association.18 This as-
sociated form was completely soluble and could be re-
versibly disrupted by heating.  Future efforts to approach 
physiological conditions will include studies at pH 7. 
 
Figure 4. Per-residue CD of 0.2 mM 1-5 in aqueous 2.5 
mM NaOAc, pH 3.8 (20º C).  
   The behavior of 1 represents a significant step toward 
modeling the unique structural properties of pathogenic 
amyloids in a soluble system. A combination of 2D 
NMR and CD data suggest that 1 can adopt a confor-
mation in which the four strand residues associate in a 
manner reminiscent of the strand arrangement in patho-
genic amyloids, with parallel β-sheet H-bonding be-
tween two pairs of strands, and side chain-to-side chain 
packing between the two parallel β-sheets. Our findings 
with linker variants 3-5 support the bioinformatics-
derived hypothesis that a five-residue loop with blbbl 
conformation allows side chain-mediated packing of 
parallel β-sheets against one another, a feature that is 
characteristic of the amyloid state.   
   Our approach to amyloid mimicry is complementary 
to those of other groups.  Eisenberg et al. have provided 
numerous crystal structures of very short peptides de-
rived from amyloidogenic proteins.23 These structures 
reveal at atomic resolution both antiparallel and parallel 
modes of side chain-mediated strand packing. Nowick et 
al. have described peptide macrocycles that enforce spe-
cific intramolecular antiparallel β-sheet H-bond regis-
tries.24 NMR and crystallographic data for these macro-
cycles elucidate specific modes of side chain-mediated 
assembly that may also occur in toxic oligomers formed 
by amyloidogenic peptides.  Collectively, these prece-
dents and our new approach to generating an amyloid 
state model in aqueous solution should be useful for ac-
quiring deeper insight on the factors that control amy-
loid stability.   
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the ACS Publications website. Figures S1-S12 and Tables 
S1-S4 along with peptide preparation, NMR, AUC, and CD 
experimental set-ups can be found in the SI. 
AUTHOR INFORMATION 
 
 
4 
Corresponding Author 
*gellman@chem.wisc.edu 
ACKNOWLEDGMENTS 
This research was supported in part by NIH grant 
R01GM061238 (SHG). DNW and GJB are supported by 
the ERC (340764), and DNW holds a Royal Society 
Wolfson Research Merit Award (WM140008). V. M. Kung 
was supported in part by the Integrated Training for Physi-
cian-Scientists program, T32 GM008692. AUC data were 
obtained at the UW-Madison Biophysical Instrumentation 
Facility, which was established with support from BIR-
9512577 (NSF) and S10-RR13790 (NIH).  The Bruker 
AVANCE 600 NMR spectrometer was supported by NIH 
grant S10-OD012245. 
REFERENCES 
1. (a) Ow, S-Y.; Dunstan, D.E. Protein Sci. 2014, 23, 1315.  (b) 
Kotler, S.A.; Walsh, P.; Brender, J.R.; Ramamoorthy, A. Chem. Soc. 
Rev. 2014, 43, 6692. (c) Jucker, M.; Walker, L. C. Nature 2013, 501, 
45.  
2. (a) Chiti, F.; Dobson, C. M. Nat. Chem. Biol. 2009, 5, 15.  (b) 
Goldschmidt, L.; Teng, P. K.; Riek, R.; Eisenberg, D. Proc. Natl. 
Acad. Sci. USA 2010, 107, 3487. 
3. (a) Petkova, A. T.; Ishii, Y.; Balbach, J. J.; Antzutkin, O.N.; 
Leapman, R.D.; Delagio, F.; Tycko, R. Proc. Natl. Acad. Sci. USA 
2002, 99, 19742. (b) Petkova, A.T.; Yau, W.; Tycko, R. Biochemistry 
2006, 45, 498. (c) Bertini, I.; Gonnelli, L.; Luchinat, C.; Mao, J.; 
Nesi, A. J Am Chem Soc. 2011, 133, 16013. (d) Lu, J.; Qiang, W.; 
Yau, W., Schwieters, C.D.; Meredith, S.C.; Tycko, R. Cell 2013, 154, 
1257.  (e) Schütz, A.K.; Vagt, T.; Huber, M.; Ovchinnikova, O. Y.; 
Cadalbert, R.; Wall, J.; Güntert, P.; Bӧckmann, A.; Glockshuber, R.; 
Meier, B. Angew. Chem. Int. Ed. 2015, 54, 331. (f) Sgourakis, N.; 
Yau, W.; Qiang, W. Structure 2015, 23, 216. (g) Xiao, Y.; Ma, B.; 
McElheny, D.; Parthasarathy, S.; Long, F.; Hoshi, M.; Nussinov, R.; 
Ishii, Y. Nat. Struct. Mol. Biol. 2015, 22, 499.  (h) Wälti, M. A.; 
Ravotti, F.; Arai, H.; Glabe, C. G.; Wall, J. S.; Böckmann, A.; Gün-
tert, P.; Meier, B. H.; Riek, R. Proc. Natl. Acad. Sci. USA 2016, 113, 
E4976.  (i) Colvin, M. T.; Silvers, R.; Ni, Q. Z.; Can, T. V.; Sergeyev, 
I.; Rosay, M.; Donovan, K. J.; Michael, B.; Wall, J.; Linse, S.; Grif-
fin, R. G. J. Am. Chem. Soc. 2016, 138, 9663.  (j) Tuttle, M. D.; 
Comellas, G.; Nieuwkoop, A. J.; Covell, D. J.; Berthold, D. A.; 
Kloepper, K. D.; Courtney, J. M.; Kim, J. K.; Barclay, A. M.; Ken-
dall, A.; Wan, W.; Stubbs, G.; Shwieters, C. D.; Lee, V. M. Y.; 
George, J. M.; Rienstra, C. M. Nat. Struct. Mol. Biol. 2016, 23, 409. 
4. (a) Comellas, G.; Rienstra, C. M. Annu. Rev. Biophys. 2013, 42, 
515. (b) Toyama, B.H.; Weissman, J. S. Annu. Rev. Biochem. 2011, 
80, 557. 
5.  Recently, formation of amyloid-like fibrils by a bacterial pep-
tide that assembles in an α-helical form has been reported:  Tayeb-
Fligelman, E.; Tabachnikov, O.; Moshe, A.; Goldscmidt-Tran, O.; 
Sawaya, J. R.; Coquelle, N.; Colletier, J. P.; Landau, M. Science 
2017, 355, 831. 
6. (a) Eisenberg, D.; Jucker, M. Cell 2012, 148, 1188. (b) Knowles, 
T. P. J.; Vendruscolo, M.; Dobson, C. M. Nat. Rev. Mol. Cell Biol. 
2014, 15, 384.   
7. (a) Greene, R. F.; Pace, C. N. J. Biol. Chem. 1974, 249, 5388.  
(b) Pace, C. N. Trends Biochem. Sci. 1990, 15, 14. 
8. For the distinction between functional and pathogenic amyloids, 
see: (a) Greenwald, J.; Riek, R. Structure 2010, 18, 1244. (b) Pham, 
C.L.L.; Kwan, A.H.; Sunde, M. Essays Biochem. 2014, 56, 207. 
9. (a) Kodali, R.; Wetzel, R. Curr. Opin. Struct. Biol. 2007, 17, 48. 
(b) Paravastu, A. K.; Leapman, R.D.; Yau, W.; Tycko, R. Proc. Natl. 
Acad. Sci. USA 2008, 105, 18349.  (c) Tycko, R. Protein Sci. 2014, 
23, 1528.  (d) Tycko, R. Neuron 2015, 86, 632. (e) Qiang, W.; Yau, 
W.-M.; Lu, J.-X.; Collinge, J.; Tycko, R. Nature 2017, 541, 217. 
10. (a) Daskalov, A.; Gantner, M.; Wӓlti, M.A.; Schmidlin, T.; 
Chi, C.N.; Wasmer, C.; Schütz, A.; Ceschin, J.; Clave, C.; Cescau, S.; 
Meier, B.; Riek, R.; Saupe, S. J. PLoS Pathog. 2014, 10, 1. (b) Wan, 
W.; Stubbs, G. Proc. Natl. Acad. Sci. USA 2014, 111, 5201.  (c) 
Wasmer, C.; Lange, A.; Melckebeke, H.; Siemer, A.; Riek, R.; Meier, 
B. Science 2008, 319, 1523.  (d) Wasmer, C.; Schütz, A.; Loquet, A.; 
Buhtz, C.; Greenwald, J.; Riek, R.; Böckmann, A.; Meier, B. J. Mol. 
Biol. 2009, 394, 119. 
11. Kung, V. M., Ph.D. Thesis, University of Wisconsin - Madi-
son, 2016. Experimental results reported here are drawn from this 
thesis. 
12. (a) Fisk, J. D.; Gellman, S. H. J. Am. Chem. Soc. 2001, 123, 
343. (b) Fisk, J. D.; Schmitt, M.A.; Gellman, S. H. J. Am. Chem. Soc. 
2006, 128, 7148. (c) Freire, F.; Almeida, A. M.; Fisk, J. D.; Steinkru-
ger, J. D.; Gellman, S. H. Angew. Chem. Int. Ed. 2011, 50, 8735.  (d) 
Kung, V. M.; Cornilescu, G.; Gellman, S. H. Angew. Chem. Int. Ed. 
2015, 54, 14336. 
13. Fisk, J. D.; Powell, D. R.; Gellman, S. H. J. Am. Chem. Soc. 
2000, 122, 5443. 
14.  Freire, F.; Fisk, J. D.; Peoples, A. J.; Invancic, M., Guzei, I. 
A.; Gellman, S. H. J. Am. Chem. Soc. 2008, 130, 7839.   
15. (a) Hennetin, J.; Jullian, B.; Steven, A. C.; Kajava, A. V.  J. 
Mol. Biol. 2006, 358, 1094. (b) Kajava, A. V.; Baxa, U.; Steven, A. C.  
FASEB J. 2010, 24, 1311. 
16. (a) Sibanda, B. L.; Thornton, J. M. Nature 1985, 316, 170.  (b) 
Sibanda, B. L.; Blundell, T. L.; Thornton, J. M. J. Mol. Biol. 1989, 
206, 759. 
17. Recent β-hairpin studies: (a) Riemen, A. J.; Waters, M. L. J. 
Am. Chem. Soc. 2010, 132, 9007. (b) Kuo, L. H.; Li, J. H.; Kuo, H. 
T.; Hung, C. Y.; Tsai, H. Y.; Chiu, W. C.; Wu, C. H.; Wang, W. R.; 
Yang, P. A.; Yao, Y. C.; Wong, T. W.; Huang, S. J.; Huang, S. L.; 
Cheng, R. P. Biochemistry 2013, 52, 7785. (c) Kier, B. L.; Anderson, 
J. M.; Andersen, N. H. J. Am. Chem. Soc. 2015, 137, 5363. (d) Sar-
nowski, M. P.; Kang, C. W.; Elbatrawi, Y. M.; Wojtas, L.; Del Valle, 
J. R. Angew. Chem. Int. Ed. 2017, 56, 2083.  (e) D'Souza, A.; Wu, X.; 
Yeow, E. K. L.; Bhattacharjya, S. Angew. Chem. Int. Ed. 2017, 56, 
5904. 
18. Please see the Supporting Information. 
19. Fesinmeyer, R. M.; Hudson, F. M.; Andersen, N. H.  J. Am. 
Chem. Soc. 2004, 126, 7238. 
20. (a) Wishart, D. S.; Sykes, B. D.; Richards, F. M. J. Mol. Biol. 
1991, 222, 311. (b) Wishart, D. S.; Sykes, B. D.; Richards, F. M. 
Biochemistry 1992, 31, 1647. 
21. (a) Wüthrich, K. NMR of Proteins and Nucleic Acids; Wiley: 
New York, 1986.  (b) Dyson, H. J.; Wright, P. E. Annu. Rev. Biophys. 
Biophys. Chem. 1991, 20, 519.   
22. (a) Greenfield, N. J. Anal. Biochem. 1996, 235, 1. (b) 
Sreerama, N.; Woody, R. W. Ana. Biochem. 2000, 287, 252. 
23. (a) Rodriguez, J. A.; Ivanova, M. I.; Sawaya, M. R.; Cascio, D.; 
Reyes, F. E.; Shi, D.; Sangwan. S.; Guenther, E. L.; Johnson, L. M.; 
Zhang, M.; Jiang, L.; Arbing, M. A.; Nannenga, B.L.; Hattne, J.; 
Whitelegge, J.; Brewster, A. S.; Messerschmidt, M.; Boutet, S.; Sau-
ter, N. K.; Gonen, T.; Eisenberg, D. S. Nature 2015, 525, 486. (b) 
Laganowsky, A.; Liu, C.; Sawaya, M. R.; Whitelegge, J. P.; Park, J.; 
Zhao, M.; Pensalfini, A.; Soriaga, A. B.; Landau, M.; Teng, P. K.; 
Cascio, D.; Glabe, C.; Eisenberg, D. Science 2012, 335, 1228. (c) 
Sawaya, M. R.; Sambashivan, S.; Nelson, R.; Ivanova, M. I.; Sievers, 
S. A.; Apostol, M. I.; Thompson, M. J.; Balbirnie, M.; Wiltzius, J. J. 
W.; McFarlane, H. T.; Madsen, A. Ø.; Riekel, C.; Eisenberg, D. Na-
ture 2007, 447, 453. (d) Nelson, R.; Sawaya, M.R.; Balbirnie, M.; 
Madsen, A. Ø.; Riekel, C.; Grothe, R.; Eisenberg, D.  Nature 2005, 
435, 773. 
243. (a) Kreutzer, A. G.; Yoo, S.; Spencer, R. K.; Nowick, J. S. J. 
Am. Chem. Soc. 2017, 139, 966.  (b) Truex, N. L.; Nowick, J. S. J. 
Am. Chem. Soc. 2016, 138, 13891. (c) Cheng, P.; Liu, C.,; Zhao, M.; 
Eisenberg, D.; Nowick, J.S. Nature Chem. 2012, 4, 927.  
 
 
5 
 
 
 
 
 
 
 
